Low Dose Aspirin is Adequate for VTE Prevention Following Total Joint Arthroplasty: A Systematic Review

Patients undergoing total joint arthroplasty(TJA) are at risk of developing venous thromboembolism(VTE) without adequate prophylaxis. Since the American Academy of Orthopedic Surgeons(AAOS) issued guidelines in 2007 recommending aspirin 325 mg BID for 6-weeks, aspirin has been favored as the main VTE prophylaxis. However, the appropriate dose and duration of aspirin are not well-studied. This systematic review aims to identify any differences between high and low dose as well as duration for aspirin thromboprophylaxis after TJA as outlined by previous studies.
Source: The Journal of Arthroplasty - Category: Orthopaedics Authors: Source Type: research